BlackRock, Inc. - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Lineage Cell Therapeutics Inc (LCTX)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: Lineage Cell Therapeutics Inc Common Stock
Symbol: LCTX
Shares outstanding: 219M shares
Disclosed Ownership: 10.1M shares
Ownership: 4.6%
Form type: SCHEDULE 13G/A
Date filed: 2/5/2025, 05:28 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	4.6%	10.1M	10.1M	0	Spencer Fleming	Managing Director